Search

Search Constraints

You searched for: Author/Creator Lefebvre, Eric

Search Results

1. A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus. (27th March 2016)

2. A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus. (27th March 2016)

3. A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. Issue 5 (29th January 2018)

4. Cenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expression. Issue 6 (8th August 2018)

5. Cenicriviroc inhibits trans‐endothelial passage of monocytes and is associated with impaired E‐selectin expression. Issue 6 (8th August 2018)

6. Cerebrospinal fluid exposure of cenicriviroc in HIV‐positive individuals with cognitive impairment. Issue 5 (4th March 2019)

7. Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury. Issue 5 (22nd July 2016)

8. Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study. Issue 3 (22nd December 2020)

9. Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV After Dual CCR2 and CCR5 Antagonism. (1st September 2018)

10. Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol‐Induced Liver Damage, Steatosis, and Inflammation in Mice. Issue 3 (12th February 2019)